PTGX
Protagonist Therapeutics Inc
143.00$
-0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 286.9% | 0.0% | – | – | 10.1% | 3.9% | 5.5% | 0.7% | 2.7% | |
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 97.3% | |
| – | – | – | 230.2% | 192.4% | 28,139.8% | 265.4% | 460.6% | 474.8% | 200.3% | 31.8% | 346.2% | |
| – | – | – | 58.7% | 44.3% | 6,817.7% | 65.1% | 99.4% | 119.4% | 55.8% | 10.0% | 97.5% | |
| – | – | – | 288.9% | 236.7% | 34,957.6% | 325.4% | 560.0% | 594.2% | 256.1% | 41.8% | 441.0% | |
| – | – | – | -188.9% | -136.7% | -34,857.6% | -225.4% | -460.0% | -494.2% | -156.1% | 58.2% | -343.6% | |
| – | – | – | 0.0% | 0.0% | 73.2% | 2.1% | 9.1% | 12.7% | – | – | – | |
| – | – | – | -184.2% | -128.4% | -33,713.4% | -226.5% | -458.9% | -479.3% | -131.6% | 64.3% | -281.0% | |
| – | – | – | -2.0% | -2.6% | -299.1% | 4.6% | -10.7% | -15.0% | -24.8% | 1.0% | 1.8% | |
| – | – | – | -184.2% | -125.9% | -33,414.3% | -231.1% | -458.9% | -464.3% | -131.6% | 63.3% | -282.8% | |
| – | – | – | -186.9% | -135.0% | -33,335.9% | -222.0% | -448.8% | -481.6% | -126.1% | 64.5% | -278.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.